NH SPAC 2 (206640.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · South Korea · ISIN KR7206640005
NH SPAC 2 financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 138.16 bn KRW | 162.09 bn KRW |
| Gross profit | 81.80 bn KRW | 95.98 bn KRW |
| Operating income | 25.98 bn KRW | 28.94 bn KRW |
| EBIT | 32.75 bn KRW | 28.19 bn KRW |
| Net income | 27.26 bn KRW | 23.65 bn KRW |
| Diluted EPS – continuing operations | 1,240.44 KRW | 1,089.60 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NH SPAC 2
Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with high-throughput; Hemochroma PLUS, a handheld device that can run tests for anemia; portable analyzers ichroma M3 and ichroma M2; and NuActor, an automated nucleic acid extraction system. It also provides compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10; cardiac reagents; cancer reagents; COVID-19 reagents; diagnostic reagents; reagents for hormones, infections, autoimmune, organ functions, molecular diagnostics, therapeutic drug monitoring, and other test items. In addition, the company offers Ichroma TRIAS, ultra-high sensitivity respiratory disease diagnostic equipment; ALFIAS-3, a diagnostic equipment; and SyncNeb. Boditech Med Inc. was founded in 1998 and is headquartered in Chuncheon-si, South Korea.
More stocks
- S Hotels and Resorts Public Company Limited (SHR.BK)
- Norsk Titanium AS (NTI.OL)
- LongDa Construction & Development Corp (5519.TW)
- Power Nickel Inc (PNPN.V)
- Ta-Yuan Cogeneration Co Ltd (8931.TWO)
- Zhong Yang Technology Co Ltd (6668.TW)
- Wah Hong Industrial (8240.TWO)
- Sang-A Frontec Co.Ltd (089980.KQ)
- Paiho Shih Holdings Corp (8404.TW)
- Ls Networks (000680.KS)
- PHA Co. Ltd (043370.KQ)
- Stack Capital Group Inc (STCK.TO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.